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Background-—Short-term exposures to ﬁne (<2.5 lm aerodynamic diameter) ambient particulate-matter (PM) have been related
with increased blood pressure (BP) in controlled-human exposure and community-based studies. However, whether coarse (2.5 to
10 lm) PM exposure increases BP is uncertain. Recent observational studies have linked PM exposures with blood DNA
hypomethylation, an epigenetic alteration that activates inﬂammatory and vascular responses. No experimental evidence is
available to conﬁrm those observational data and demonstrate the relations between PM, hypomethylation, and BP.
Methods and Results-—We conducted a cross-over trial of controlled-human exposure to concentrated ambient particles (CAPs).
Fifteen healthy adult participants were exposed for 130 minutes to ﬁne CAPs, coarse CAPs, or HEPA-ﬁltered medical air (control) in
randomized order with ≥2-week washout. Repetitive-element (Alu, long interspersed nuclear element-1 [LINE-1]) and candidate-
gene (TLR4, IL-12, IL-6, iNOS) blood methylation, systolic and diastolic BP were measured pre- and postexposure. After adjustment
for multiple comparisons, ﬁne CAPs exposure lowered Alu methylation (b-standardized= 0.74, adjusted-P=0.03); coarse CAPs
exposure lowered TLR4 methylation (b-standardized= 0.27, adjusted-P=0.04). Both ﬁne and coarse CAPs determined signiﬁcantly
increased systolic BP (b=2.53 mm Hg, P=0.001; b=1.56 mm Hg, P=0.03, respectively) and nonsigniﬁcantly increased diastolic BP
(b=0.98 mm Hg, P=0.12; b=0.82 mm Hg, P=0.11, respectively). Decreased Alu and TLR4 methylation was associated with higher
postexposure DBP (b-standardized=0.41, P=0.04; and b-standardized=0.84, P=0.02; respectively). Decreased TLR4 methylation
was associated with higher postexposure SBP (b-standardized=1.45, P=0.01).
Conclusions-—Our ﬁndings provide novel evidence of effects of coarse PM on BP and conﬁrm effects of ﬁne PM. Our results
provide the ﬁrst experimental evidence of PM-induced DNA hypomethylation and its correlation to BP. (J Am Heart Assoc.
2013;2:e000212 doi: 10.1161/JAHA.113.000212)
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A
ir pollution is a major public health concern in the United
States and worldwide, accounting for approximately
800 000 deaths annually.
1 Historical episodes of accumula-
tions of ambient particulate matter (PM), such as in London in
December 1952 or in Donora Valley in the last 3 days of
October 1948, have been associated with up to >10 times
increased death rates, mostly from cardiovascular disease
(CVD).
2 In the past 30 years, massive efforts in controlling
emissions have led to substantial lowering of air pollution
levels. However, in the presence of stagnating weather, peaks
more than 10 times higher than the background levels of PM
pollution are still frequently recorded in U.S. cities
3 and
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ORIGINAL RESEARCHfollowed by increased CVD hospitalization and mortality
within hours or days.
4,5 A recent comparative study showed
that PM and trafﬁc pollution exposures, because they expose
millions to unhealthy air, are among the most frequent
triggers of myocardial infarction at the population level, with
about twice as many events as heavy alcohol consumption
and >10 times than cocaine abuse.
6 As recently as in July
2012, warnings for unhealthy PM levels were issued for most
large U.S. cities, as reported by the U.S. Environmental
Protection Agency.
3
Blood pressure (BP) can change rapidly in response to
environmental stressors
7,8 and has been proposed as a
primary intermediate response for acute PM-related cardio-
vascular events.
4,7 Airborne PM ≤2.5 lm (PM2.5 or ﬁne
particles) in aerodynamic diameter, as well as larger particles
between 2.5 and 10 lm (coarse particles), can be inhaled and
deposited in the upper and lower airways. Because of their
smaller size, ﬁne particles can reach more deeply into the
lungs and have been suggested to have more harmful effects
on cardiovascular outcomes.
4 Observational data and previ-
ous studies of controlled human exposures have reproducibly
shown rapid adverse effects on BP as early as 2 hours during
PM exposure.
7,9 An increase as small as 1 mm Hg in usual
systolic BP is estimated to increase the risk of CVD deaths by
2% to 4%,
10,11 and transient increases have been linked to
PM-related triggering of cardiovascular events.
4,12 The limited
understanding of the mechanisms linking air pollution expo-
sure to cardiovascular outcomes, including effects on BP, is
identiﬁed as a critical research and clinical gap in a 2010
statement of the American Heart Association.
4
DNA methylation, the most studied of the epigenetic
mechanisms, is a natural process that suppresses gene
expression via addition of methyl groups to the DNA. Loss of
methylation in inﬂammatory genes has been shown in
lymphocytes as early as 20 minutes after antigen presenta-
tion.
13 Findings from human observational studies have
suggested that PM exposure may determine loss of methyl-
ation in blood DNA, potentially reﬂecting activation of
proinﬂammatory states in blood leukocytes.
14 Speciﬁcally,
PM-related hypomethylation has been repeatedly observed in
transposable repeated elements, including Alu
15–17 and long
interspersed nuclear element-1 (LINE-1),
15–18 as well as in
candidate proinﬂammatory genes.
16 Consistent with these
observations, reduced methylation of genomic DNA in blood
has also been observed in patients with cardiovascular
disease,
14,19 or CVD-related conditions and risk factors,
including atherosclerosis,
20 oxidative stress,
21 and aging.
22
However, current evidence on PM-induced hypomethylation
rests entirely on observational studies, and no human
experimental data are yet available to demonstrate effects
of air pollution on DNA methylation. In addition, whether
PM-induced hypomethylation mediates the effects of PM on
cardiovascular outcomes, such as those on BP, has never
been tested.
Controlled studies on human-exposure to concentrated
ambient particles (CAPs) provide a unique opportunity to
simulate air pollution peaks, while allowing for experimental
control of the exposures. Previous controlled human exposure
experiments have shown increased BP after exposure to ﬁne
CAPs
9,23—consistent with observational studies that have
associated short-term PM2.5 exposure with BP.
4 To the best of
our knowledge, changes in BP after coarse CAP exposure
have not yet been documented. Albeit mostly deposited and
cleared in the upper airways, coarse particles are enriched in
organic components that activate innate inﬂammatory
responses.
24 Activation of speciﬁc innate immune responses
in circulating leukocytes, such as those mediated through
increased expression of the toll-like receptor-4 (TLR4), have
been linked with BP and hypertension.
25 Herein, we report the
results of a double-blind randomized cross-over trial of
controlled human exposures to ﬁne and coarse CAPs. We
experimentally determined effects on blood DNA methylation
of LINE-1 and Alu repetitive elements and candidate proin-
ﬂammatory genes (TLR4, IL-12, IL-6, iNOS). In addition to
evaluating CAPs effects on blood DNA methylation, we tested
for CAPs-induced effects on BP and conducted mediation
analysis to estimate the proportion of the effects on BP
mediated by DNA methylation.
Materials and Methods
Study Participants
The study included 15 healthy volunteers between 18 and
60 years of age. All participants were nonsmokers and free of
CVD. All experiments were conducted between January 2008–
March2010attheGageOccupationalandEnvironmentalHealth
Unit, University of Toronto, Ontario, Canada. Exclusion criteria
included a fasting total cholesterol >6.2 mmol/L, glucose
>7 mmol/L, hypertension (resting BP >140/90 mm Hg),
pregnancy/lactation, orECG abnormalities. The study received
institutional review board approval from St. Michael’s Hospital
and University of Toronto. All participants provided written
informed consent before enrolling.
Study Design and Exposure Protocol
Using a double-blind randomized placebo-controlled cross-
over design, each participant underwent 3 exposures in
random order: (i) ﬁne CAPs; (ii) coarse CAPs; and (iii) High-
Efﬁciency-Particulate-Air (HEPA)-ﬁltered medical air (control),
separated by a minimum 2-week washout period. Volunteers
and study personnel were blinded to the exposure order. Only
the technologist who generated the exposure was aware of
DOI: 10.1161/JAHA.113.000212 Journal of the American Heart Association 2
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facility that concentrates ﬁne or coarse particles under
controlled conditions, using high-ﬂow (5000 L/min) Harvard
ambient particle concentrators (see details in Data S1).
Brieﬂy, ambient particles were drawn into a 1.8 m high PM10
inlet located 10 m from a busy 4-lane downtown Toronto
street, with  2500 vehicles passing during the 130-minute
exposure. The CAP airstream was delivered directly to the
volunteer who was seated inside a Lexan and steel tube frame
enclosure (4.9 m
3, see exposure apparatus during one of the
experiments in Figure S1). Participants were at rest and
breathing freely (no mouthpiece) via an “oxygen type”
facemask covering their nose and mouth.
26 The target levels
for the ﬁne and coarse CAP experiments were 250 and
200 lg/m
3, respectively. The CAP/ﬁltered air delivery sys-
tem was designed so that there were no visual cues as to the
exposure type while participants were seated in the exposure
chamber.
BP Measures and Blood Sample Collection
All participants fasted (>8 hours) prior to their arrival at the
facility at  7:30 AM. Blood samples were collected at  9 AM.
Afterward, volunteers underwent the 130-minute exposure, at
rest. Seated BP was obtained 10 minutes before exposure
and 5 minutes after completion of the exposure. Postexpo-
sure blood samples were collected  1 hour after the end of
the exposure. A standardized protocol for BP measurements
was used as recommended by the American Heart Associa-
tion (see Data S1, Figure S2).
27
DNA Methylation Analyses
Buffy coat was immediately obtained from blood in a
preprocessing laboratory adjacent to the exposure facility,
aliquoted, and frozen at  20°C until DNA isolation. All
laboratory procedures on the buffy-coat samples, from DNA
isolation through DNA methylation analyses, were performed
in a single batch. DNA was puriﬁed using Qiagen DNeasy
Blood and Tissue Kit (Qiagen). All samples from each
participant were placed on the same analytical plate to avoid
plate effects. DNA methylation analyses were performed by
bisulﬁte PCR-Pyrosequencing. We performed DNA methyla-
tion analyses of Alu and LINE-1 repeated sequences, as
described previously,
16 which allows for the ampliﬁcation of a
representative pool of repetitive elements. We developed
assays for TLR4, IL6, IL12, and iNOS methylation by locating
their promoters using the Genomatix Software (Genomatix
Software Inc) and ampliﬁed the sequences shown in Tables S1
and S2. In each assay, we measured %5mC at multiple CpG
dinucleotides (Table S1). Every sample was tested in duplicate
to conﬁrm reliability.
Statistical Analysis
In each blood sample, DNA methylation analysis produced 8
values each for LINE-1 and TLR4 (methylation at 4 CpGs
replicated in 2 runs), 6 values for Alu (methylation at 3 CpGs
replicated in 2 runs), and 4 values each for IL-6, IL-12, and
iNOS (methylation at 2 CpGs replicated in 2 runs). In addition,
methylation was measured in each participant at 2 time
points (pre- and postexposure) in each of the 3 randomized
experiments. To account for this data structure and consider
within-individual effects, we used mixed-effect models (PROC
MIXED in SAS V9.2).
16 We ﬁtted mixed-effect models with a
random intercept for each subject—which captures the
correlation among measurements within the same subject; a
random intercept for each CpG—which captures the corre-
lation among measurements within the same CpG position;
and a random slope for each position—which captures
potential different effects of the exposures across the
different positions. To control for potential confounding due
to period effect, we also included a numeric variable
indicating the order of exposure.
For each DNA methylation marker we assumed the
following:
Yijkl ¼ b0 þ li þ l0j þ b1ðfineÞþl1jðfineÞþb2ðcoarseÞ
þ l2jðcoarseÞþb3ðpostÞþb4ðfine   postÞ
þ b5ðcoarse   postÞþb6ðorderÞþeijkl
(1)
where Yijkl is the value of methylation in subject i, CpG
position j, time k (pre- or postexpsosure) and experiment l
(ﬁne CAPs, coarse CAPs, or medical air); b0 is the overall
intercept, which indicates the average methylation in the
control group (medical air) in preexposure samples; li is the
random intercept for the subject i; l0j is the random intercept
for each position; b1 and b2 are the main effects of the
exposure to ﬁne CAPs and to coarse CAPs, respectively,
compared to the control exposure; b3 is the main effect of
time (postexposure compared to preexposure); l1j and l2j are
the random slopes of the different CpG positions for each
exposure; b4 and b5 are the interaction effects between
exposure (ﬁne and coarse, respectively) and time; b6 repre-
sents the period effect.
The choice of the 6 methylation markers, and of BP as the
clinical outcome, was made a priori. No other methylation
markers or outcomes were examined. P values from the
model described in equation 1 were adjusted for multiple
comparisons using a permutation test that accounts for data
correlation.
28 Methylation data are expected to be correlated
and statistical tests are likely to be not independent. In this
situation, commonly used methods of multiple-testing
correction such as Bonferroni and FDR will overestimate
the adjusted P value. Permutation test represents a straight-
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approach to correct for multiple comparisons.
28 Brieﬂy, we
randomly permuted the exposures within subject and then
regressed each of the 6 DNA methylation markers over the
exposures on this permuted dataset. The permutation breaks
the link in the data between the exposures and DNA
methylation, thus the dataset generated will be under the
null hypothesis. We repeated this process 1000 times. A total
of 12 000 P values (6 genes91000 datasets92 exposures)
were obtained. The adjusted permutation P value was equal to
the number of simulations with P value smaller than the
observed P value divided by 12 000. Adjusted permutation P
values <0.05 were considered signiﬁcant and reported
alongside the nominal 95% CIs and P values.
We then examined the effects of the exposures on systolic
or diastolic BP by using the following mixed-effect models:
Yikl ¼ b0 þ li þ b1ðfineÞþb2ðcoarseÞþb3ðpostÞ
þ b4ðfine   postÞþb5ðcoarse   postÞþb6ðorderÞ
þ eikl
(2)
where Yikl is the measured value of either systolic or diastolic
BP for subject i, time k, and experiment l; b0 is the overall
intercept, which indicates the average value of BP in the
control group (medical air) preexposure; b1 and b2 are the
main effects of the exposure, respectively, to ﬁne CAP and to
coarse CAP compared to the control exposure; li is the
random intercept for the subject i; b3 is the main effect of
time (postexposure compared to preexposure); b4 and b5 are
the interaction effects between exposure (ﬁne and coarse,
respectively) and time; b6 represents the period effect.
From the regression coefﬁcients of the models in equa-
tions 1 or 2, group means can be derived as the average
values of the dependent variables for each combination of
exposure and time. In our primary analysis, we present within-
subject mean differences between postexposure measure-
ments (ie, ﬁne versus medical air; and coarse versus medical
air). For those outcomes showing a statistically signiﬁcant
difference, we are also reporting differences between pre- and
postexposure means.
We ﬁnally evaluated the association of the DNA methyl-
ation markers with systolic or diastolic BP levels in postex-
posure measures. To reduce multiple testing, we prioritized
and present in the paper only the results for the methylation
markers that showed signiﬁcant differences after either ﬁne
or coarse CAP exposure. For both systolic and diastolic BP,
we assumed the following model:
Yikl ¼ b0 þ li þ b1ðmethylationÞþeikl (3)
where Yikl is the measured value of either systolic and
diastolic BP for subject i, time k, and experiment l; b0 is the
overall intercept; b1 is the regression coefﬁcient for each the
DNA methylation ﬁtted as the mean of CpG positions and
runs; li is the random intercept for the subject. A nominal P
value <0.05 was considered statistically signiﬁcant.
Mediation Analysis
We performed mediation analysis to estimate the proportion
of the exposure effects on BP mediated by DNA methylation.
Based on the a priori assumption that a mediated effect is
biologically plausible, this approach decomposes the total
observed effect of exposure on BP into a direct effect of
exposure and an indirect effect of exposure that acts via the
mediator of interest
29,30 (ie, DNA methylation). Mediation
analysis usually requires a signiﬁcant relation of the outcome
to the exposure, a signiﬁcant relation of the outcome to the
mediator and a signiﬁcant relation of the mediator to the
exposure;
31 as potential mediators, we therefore analyzed the
methylation markers that satisﬁed all these assumptions. In
order to establish mediation, a signiﬁcant relation of the
mediator to the outcome, when both the mediator and the
exposure are predictors, is also required. To test the latter
assumption we evaluated the potential mediators in the
following model:
Yikl ¼b0 þ li þ b1ðmethylationÞþb2ðfineÞþb3ðcoarseÞ
þ eikl
(4)
where Yikl is the measured value of BP (either systolic or
diastolic) for subject i, time k, and experiment l; b0 is the
overall intercept; li is the random intercept for the subject; b1
is the regression coefﬁcient for each CpG position; b2 and b3
are the main effects of the exposure to ﬁne and coarse CAPs,
respectively, relative to the medical air control exposure.
Once all these assumptions are veriﬁed, it is possible to
evaluate the indirect effect, which estimates the size of the
effect of CAPs exposure on BP that is mediated by DNA
methylation.
32 We estimated the indirect effect via a mixed-
effect mediation model using PROC MIXED in SAS 9.2.
29,30
Results
Effects of Controlled Exposures on DNA
Methylation
Table 1 shows the baseline characteristics of the study
participants. The study included 8 male and 7 female
participants (average age 27.7 years). The actual average
levels of PM mass concentrations achieved during the
experiments were 241.8 lg/m
3, 210.6 lg/m
3, and 0.6 lg/
m
3 during the ﬁne CAP, coarse CAP, and control exposures,
respectively.
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methylation in blood samples collected after exposures to
CAPs (ﬁne or coarse) relative to the medical air control
exposure, taken as reference (ie, mean within-subject differ-
ences between postexposure measurements obtained from
model [1]); because methylation showed large between-
marker differences in mean and range of values, to allow for
comparability we report standardized bs expressing the
difference between exposures as a fraction of the SD of
DNA methylation. Alu methylation was signiﬁcantly lower after
ﬁne-CAPs exposure (standardized b=-0.74, P=0.0006), com-
pared to postmedical air (control) exposure. TLR4 methylation
was signiﬁcantly lower after both ﬁne- (standardized b=-0.21,
P=0.02) and coarse CAPs (standardized b=-0.27, P=0.01)
exposures, relative to the postcontrol exposure (Figure 1).
After P value adjustment for multiple comparisons, the
postexposure difference in Alu methylation between ﬁne
CAPs and medical ﬁltered air remained signiﬁcant (permuta-
tion-adjusted P=0.03). The effect on TLR4 methylation
remained signiﬁcant for coarse CAPs (permutation-adjusted
P=0.04), but not for ﬁne CAPs (permutation-adjusted P=0.08).
No signiﬁcant differences were observed in postexposure
LINE-1, IL-6, IL-12,o riNOS methylation. Postexposure com-
parisons for each of the 6 methylation markers are reported in
Table S5.
We conﬁrmed these ﬁndings by evaluating the average
within-participant change in DNA methylation in postexposure
relative to preexposure blood samples in each of the 3
exposures(ﬁneCAPs,coarseCAPs,orcontrol).Alumethylation
Table 1. Characteristics of the Study Participants at the
Enrollment Visit*, n=15
Characteristics Mean SD or n (%)
Age, y 27.7 8.6
Gender
Male 8 (53.3)
Female 7 (46.7)
Race
White 10 (66.7)
Black 1 (6.7)
Asian 4 (26.6)
BMI, kg/m
2 23.2 2.4
Fasting glucose, mmol/L 4.8 0.5
Fasting cholesterol, mmol/L 4.2 0.7
Heart rate, beats/min 67.9 12.6
Systolic BP, mm Hg 117.6 14.1
Diastolic BP, mm Hg 69.1 12.2
White blood cell count, 109/L 5.5 1.1
DNA methylation, % 5mC
Alu 24.2 0.5
LINE-1 84.3 0.7
TLR4 3.6 0.8
IL-6 45.5 7.4
IL-12 94.9 0.7
iNOS 62.9 2.8
BMI indicates body mass index; BP, blood pressure; LINE-1, long interspersed nuclear
element-1; TLR4, toll-like receptor-4; IL-6, interleukin 6; IL-12, interleukin 12; iNOS,
inducible nitric oxide synthase gene.
*Variables assessed at a preliminary screening visit conducted before the beginning of
the experiments except DNA methylation—methylation values were measured on blood
samples collected before the ﬁrst exposure experiments.
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-0.6
-0.4
-0.2
0
0.2
0.4
0.6
Alu LINE-1 TLR4 IL-6 IL-12 iNOS
Effect of coarse CAPs on DNA methylation, relative to control
Nominal P = 0.01
Adjusted P = 0.04
B
-1.2
-1
-0.8
-0.6
-0.4
-0.2
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0.4
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Effect of fine CAPs on DNA methylation, relative to control
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Figure 1. Effect of controlled exposures to ﬁne CAPs (A) and
coarse CAPs (B) on blood DNA methylation. Differences in CAPs vs
medical air (control) exposures of DNA methylation in postexposure
samples reported as standardized bs and 95% conﬁdence intervals.
bs indicate the differences between CAPs exposure and control
exposure (HEPA-ﬁltered medical air) in the postexposure blood
samples. bs are standardized to express the effect of CAPs exposure
on DNA methylation as a fraction of the standard deviation of DNA
methylation. Nominal P values (P), as well as P values adjusted for
multiple testing (adjusted P) are shown for the signiﬁcant effects.
CAP indicates concentrated ambient particle; HEPA, high-efﬁciency
particulate air; LINE-1, long interspersed nuclear element-1; TLR4,
toll-like receptor-4; IL-6, interleukin 6; IL-12, interleukin 12; iNOS,
inducible nitric oxide synthase gene.
DOI: 10.1161/JAHA.113.000212 Journal of the American Heart Association 5
DNA Methylation, PM, and Blood Pressure Bellavia et al
O
R
I
G
I
N
A
L
R
E
S
E
A
R
C
Hshowed a signiﬁcant average within-participant decrease in
postexposure samples after ﬁne CAPs exposure (standardized
b= 0.40, P=0.05), and no change after coarse CAPs (stan-
dardized b=0.02, P=0.86) or control exposures (standardized
b=0.20, P=0.26). TLR4 methylation showed a signiﬁcant
average within-participant decrease after ﬁne (standardized
b= 0.21, P=0.02) and coarse (standardized b= 0.16,
P=0.05) CAPs exposures, and no signiﬁcant changes after
control exposure (standardized b=0.11, P=0.28).
Effects of Controlled Exposures on BP
Figure 2 shows the average BP differences after exposures to
CAPs (ﬁne or coarse) relative to the control exposure, taken
as reference (ie, mean within-subject differences between
postexposure measurements obtained from model [2]);.
Systolic BP postexposure was signiﬁcantly higher after
exposure to ﬁne (b=2.53 mm Hg, P=0.001) and coarse
(b=1.56 mm Hg, P=0.03) CAPs relative to measurements
after the control exposure. Postexposure differences in
diastolic BP were not statistically signiﬁcant (Figure 2).
To conﬁrm these ﬁndings, we also estimated the average
within-participant BP change in postexposure measurements
relative to preexposure for each of the 3 exposures. Both
systolic and diastolic BP showed signiﬁcant average within-
participant postexposure increases after ﬁne CAPs
(b=2.97 mm Hg,P=0.002forsystolicBP;andb=1.87 mm Hg,
P=0.005 for diastolic BP), and coarse CAPs (b=2.11 mm Hg,
P=0.0008 for systolic BP; and b=2.36 mm Hg, P=0.0007 for
diastolic BP). However, as expected due to normal circadian
variations in BP, we also found in the control experiments a
moderate postexposure increase in systolic BP
(b=0.25 mm Hg, P=0.74) and a stronger increase in diastolic
BP (b=1.83 mm Hg, P=0.006), albeit both were less pro-
nouncedthan those found afterﬁneorcoarseCAPsexposures.
Association of DNA Methylation With Blood
Pressure
To reduce false positive ﬁndings from multiple testing, we
prioritized and present only the results on the association
between DNA methylation and BP for the 2 markers that
showed effects from CAP exposures, that is, Alu and TLR4.
Decreased Alu methylation was associated with signiﬁcantly
increased diastolic BP (b=0.41, P=0.04) and nonsigniﬁcantly
increased systolic BP (b=0.40, P=0.15). Decreased TLR4
methylation was associated with signiﬁcant increases of both
diastolic (b=0.84, P=0.02) and systolic BP (b=1.45, P=0.01).
Analyses stratiﬁed by exposure type showed correlations
between DNA methylation and BP substantially homogeneous
across the different exposures (data not shown) (Figure 3).
Sensitivity Analyses
By study design, exposure-order randomization is expected to
balance potential confounders across exposure groups. We
adjusted in our primary analysis for experiment order to limit
confounding from random order imbalances. Moreover, by
ﬁtting a random intercept for each participant, our modeling
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Figure 2. Effect of controlled exposures to ﬁne concentrated
ambient particles (CAPs) and coarse CAPs on systolic and diastolic
blood pressure (BP). Differences in CAPs vs medical air (control)
exposures of systolic and diastolic BP in postexposure measure-
ments. bs and 95% conﬁdence intervals expressing the difference in
BP (mm Hg) between CAPs exposures and control exposure (HEPA-
ﬁltered medical air) in postexposures measurements. HEPA indicates
high-efﬁciency particulate air.
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Figure 3. Associations of Alu and TLR4 methylation with systolic
and diastolic blood pressure (BP). Standardized bs and 95%
conﬁdence intervals are shown in the ﬁgure. Standardize bs express
the changes in BP as fractions of the BP standard deviation
associated with a decrease in DNA methylation equal to its standard
deviation. TLR4 indicates toll-like receptor-4.
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that do not vary over time. A source of residual confounding
may be represented by carryover effect. To control for this
potential confounder we performed a sensitivity analysis
adjusting models (1) and (2) for the previous exposure (binary
variable indicating if the previous exposure was either CAPs or
medical air). No major differences in the results were
observed (Tables S6 and S7). As additional sensitivity
analyses, multiple regression models were ﬁtted to control
for potential time-varying confounders such as white blood
cell counts and proportions of blood leukocyte cell types in
differential blood counts (neutrophils, lymphocytes, mono-
cytes, eosinophils, and basophils). We ﬁrst checked if there
was any difference in blood cell proportions between pre- and
postexposure samples or when comparing exposure types in
postexposure blood samples, and found no statistically
signiﬁcant differences (Table S8 and S9). Nonetheless, we
further adjusted model (1) for white blood cell counts and
proportions of blood leukocyte cell to exclude potential
inﬂuences on DNA methylation. Results from these adjusted
models (Table S10) were similar to those from our primary
analysis.
Mediation Analysis
We performed mediation analysis to estimate the proportion
of the effects of the exposures on BP that were mediated by
postexposure changes in DNA methylation. Alu methylation
satisﬁed the underlying assumptions for mediation analysis,
described in the methods section, as it showed signiﬁcant
associations with ﬁne CAPs exposures (b= 0.74, adjusted P
value=0.03), as well as with systolic BP in the model including
both Alu methylation and ﬁne CAPs exposure as independent
predictors (b= 0.37, P=0.03). These results fulﬁll the
assumptions for mediation analysis; therefore, we considered
the potential pathway of ﬁne CAPs exposure, Alu methylation
and systolic BP and estimated indirect effect and proportion
of mediation.
In the mediation analysis models, estimates of the
proportion of mediation indicated that Alu hypomethylation
mediated 10% of the positive association between ﬁne CAP
exposure and systolic BP (indirect effect: 0.40).
Discussion
In the present study of controlled human exposures, ﬁne and
coarse CAPs induced blood hypomethylation of the Alu
repetitive elements and TLR4 gene. Hypomethylation of both
Alu and TLR4 was found to be associated with increased
systolic BP after the exposures. A wealth of epidemiological
studies have reported associations between peaks of ambient
particulate matter exposure and cardiovascular disease and
deaths.
4,5 Several biological mechanisms that may in part
explain these ﬁndings have been reported through the use of
controlled human exposures to CAPs.
4 Blood pressure, a well-
known predictor of cardiovascular risk, has been shown to
exhibit small, but potentially critical acute increases in
response to ﬁne CAPs exposures.
9 Decreased global and
gene-speciﬁc DNA methylation has been proposed as a novel
mechanism mediating the effect of air pollution exposure to
CVD-related events.
19 Castro et al
20 found lower DNA
methylation content in peripheral blood leukocytes from
patients with atherosclerotic cardiovascular disease. Further-
more, recent ﬁndings from the Normative Aging Study have
shown that lower blood LINE-1 methylation predicts incidence
and mortality from ischemic heart disease and stroke.
14
Processes related to cardiovascular disease, such as oxidative
stress,
21 atherosclerosis,
20 and aging
22 have been associated
with lower DNA methylation content in blood. In vascular
tissues, hypomethylated DNA has been shown to be prone to
mutations or aberrant gene expression patterns leading to the
transition from a normal phenotype to vascular ﬁbrocellular
lesions by increasing proliferation of vascular smooth cells
and lipid deposition.
20
Previous in vitro experiments have shown that repetitive-
element and gene-speciﬁc hypomethylation is induced by
biological processes, such as oxidative stress,
21 which are
generated by PM in exposed individuals.
4 Oxidative DNA
damage can interfere with the ability of methyltransferases to
interact with DNA,
21 thus resulting in hypomethylation of
cytosine residues at CpG sites. The association between
ambient particle exposure and DNA methylation has been
observed in repetitive elements, such as Alu and LINE-1,
15 in
innate immune and proinﬂammatory pathways (TLR4, IL-12,
IL-6),
17,18 and in the inducible nitric oxide synthase gene
(iNOS).
16
In our study, Alu and TLR4 methylation were found to be
signiﬁcantly lower after CAPs exposures, providing for the ﬁrst
time—to the best of our knowledge—direct experimental
evidence that PM exposure induces DNA hypomethylation in
humans. We also observed a signiﬁcant increase in systolic
BP after CAPs exposures, conﬁrming previous results on ﬁne
particle exposure
4 and providing novel experimental evidence
indicating that coarse exposure induces cardiovascular
responses. Our ﬁndings also provide results consistent with
the hypothesis that rapid hypomethylation of Alu and TLR4 is
an epigenetic mechanism that mediates the effects of particle
exposure on BP. Activation of Alu repetitive elements, which is
associated with hypomethylation of genomic DNA, increases
in older individuals and has been suggested to contribute to
biological aging and age-related chronic disease.
33 Nearly 1
million copies of Alu sequences are dispersed throughout the
genome.
34 Alu methylation states have been shown to control
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34
Previous studies have linked the presence of Alu sequences in
a number of genes related with hypertension—including the
serine/threonine protein kinase family member WNK1,
35
angiotensin I converting enzyme,
36,37 tissue-type plasminogen
activator,
38 and 11beta-hydroxysteroid dehydrogenase type 2.
39
Whether the association found in our study between global
Alu hypomethylation and BP is driven by hypomethylation of
speciﬁc Alu sequences in these genes, or in other genomic
regions, remains to be determined.
Recent investigations have consistently indicated that
expression of TLR4 on circulating leukocytes may act as a
primary communication between the innate immune system
and systemic vascular functions. Experimental models have
shown that TLR4, which is activated by endotoxin contained in
PM, contributes to induce PM-related inﬂammation, oxidative
stress, and CVD-related responses.
40,41 Kampfrath et al
40
showed that TLR4 deﬁciency prevented the increased micro-
vascular vasoconstriction induced in mice by PM2.5 exposure,
as well as PM-related inﬂammatory and oxidative-stress
responses. Bonﬁme ta l
41 showed that TLR4 inactivation with
anti-TLR4 antibodies reduced the mean arterial pressure in
spontaneously hypertensive rats. Recent molecular studies
have shown that TLR4 binds a wide range of endogenous
ligands related to BP regulation and cardiovascular function,
including angiotensin II (AT-II), heat shock protein, ﬁbrinogen,
and ﬁbronectin.
41 Downstream products of TLR4 signaling
include thromboxane A2, a potent vasoconstrictor that can
induce rapid increases in BP.
42 TLR4 expression is increased
in both peripheral mononuclear leukocytes and cardiac
tissues of hypertensive patients.
25,43 Our results are consis-
tent with these animal models that indicated PM-induced
activation of TLR4 pathways as integral to PM-related
cardiovascular effects.
Results from regression models in the present study were
reported as standardized beta that indicated the effects of the
exposuresasafractionofaSDoftheDNAmethylationmarkers.
This presentation allowed to compare the size of CAPs effects
across different markers and also showed that the effects of
CAPs on DNA methylation were sizable relative to the methyl-
ationSDs,as—forinstance—theyamountedtoasmuchas74%
of the SD of Alu methylation. However, the SDs of both Alu and
TLR4 were small, thus indicating that Alu and TLR4 methylation
is tightly regulated. These ﬁndings suggest that even small
changes in absolute DNA methylation, potentially correspond-
ing to profound demethylation in a subset of blood leukocytes,
may lead to effects on BP. In our study, CAP exposures did not
show consistent effects on LINE-1 methylation. Methylation
measures in LINE-1 and Alu repetitive elements have been
proposed as markers of genomic DNA methylation content
based on results in cancer cells.
33 However, the 2 repetitive
elementsarecontrolledthroughdifferentmechanismsandhave
beenshowntohavedifferenttranscriptionpatternsinresponse
to environmental stressors and other conditions.
33 For
instance, Alu—but not LINE-1—methylation has been shown
to decrease through aging,
33 potentially reﬂecting differential
susceptibility to cumulative environmental insults over time.
Our data provide further evidence that Alu and LINE-1 methyl-
ation have different sensitivities to environmental stressors,
15
and that they can show different associations with cardiovas-
cular outcomes, such as increased BP. In contrast to previous
evidence from in vitro and observational investigations,
16–18
CAPsexposuresdidnotaffectIL-6,IL-12,oriNOSmethylationin
our study. Despite the advantage of using high-precision
quantitative pyrosequencing measures, the lower number of
CpG sites analyzed in these genes, compared to those
measured in Alu and TLR4, may have limited our capability to
detectpotentialeffects.BloodDNA is derivedfrom a mixed cell
population of different types of circulating white blood cells.
Therefore, our ﬁndings on DNA methylation may have resulted
from a CAP-induced shift in cell populations. However, CAPs
exposure had no signiﬁcant effects on the proportions of the
major leukocyte cell types and sensitivity analysis showed no
substantial differences in the results from models adjusted for
leukocyte total count and proportions of neutrophils, lympho-
cytes, monocytes, basophils, and eosinophils. Although these
ﬁndingslimitthechancesthatshiftsonmajorcelltypesunderlie
CAP-induced effectsonDNAmethylation,itisstillpossiblethat
our results may be driven by changes in other smaller
subpopulations, such as the different types of circulating
lymphocytes. TLR4 has been found to be expressed in a variety
of hematopoietic cells, including lymphocytes, monocytes, and
myeloid cells.
24 Future studies are needed to conﬁrm our
ﬁndings and determine the cell compartment responsible for
the observed changes. Finally, the volunteers enrolled in the
present study were healthy and not necessarily representative
of the general population. Our results may not be generalizable
to different population strata and, particularly, should be
replicated in a higher risk population. Moreover, the relatively
small sample size might have limited our capability to detect
signiﬁcant effects.
In conclusion, our results demonstrate for the ﬁrst time in
a human experimental study that PM exposure induces rapid
DNA hypomethylation. Alu and TLR4 hypomethylation may
represent a novel mechanism that mediates environmental
effects on BP.
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